AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
May 16, 2011
30583_dirs_2011-05-16_d7adb96a-c79c-4ad0-8171-dc1c0f6ea4ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-12
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-29 | Common Stock | A | 1447 | $11.6365 | Acquired | 69160 | Direct |
| 2011-05-12 | Common Stock | A | 10000 | — | Acquired | 79160 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-12 | Stock Option (right to buy) | $26.49 | A | 80000 | Acquired | 2021-05-11 | Common Stock (80000) | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of November 1, 2010 to April 29, 2011.
F2: Restricted stock units granted on May 12, 2011. Price not applicable.
F3: Options vest 6/48ths on November 12, 2011 and 1/48th on the 12th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19